Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: impact on clinical and hemodynamic parameters, quality of life and …

P Jansa, S Heller, M Svoboda, M Pad'our… - Journal of clinical …, 2020 - mdpi.com
Balloon pulmonary angioplasty (BPA) is a novel treatment option for patients with chronic
thromboembolic pulmonary hypertension (CTEPH) who are not eligible for pulmonary …

Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension in Greece: data from the Hellenic Pulmonary Hypertension Registry

P Karyofyllis, E Demerouti, G Giannakoulas… - Journal of Clinical …, 2022 - mdpi.com
Balloon pulmonary angioplasty (BPA) is a novel and promising treatment option for patients
with chronic thromboembolic pulmonary hypertension (CTEPH) who are ineligible for …

[HTML][HTML] Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry

S Darocha, M Roik, G Kopeć, A Araszkiewicz… - …, 2022 - ncbi.nlm.nih.gov
Background Balloon pulmonary angioplasty (BPA) is a promising therapy for patients with
chronic thromboembolic pulmonary hypertension (CTEPH) who are ineligible for pulmonary …

Balloon pulmonary angioplasty in patients with inoperable or recurrent/residual chronic thromboembolic pulmonary hypertension: a single-centre initial experience

H Atas, B Mutlu, D Akaslan, D Kocakaya… - Heart, Lung and …, 2022 - Elsevier
Background Patients with inoperable chronic thromboembolic pulmonary hypertension
(CTEPH) are often treated with pulmonary arterial hypertension-specific drugs. However …

[HTML][HTML] Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension

Y Taniguchi, K Miyagawa… - …, 2014 - eurointervention.pcronline.com
Aims: To evaluate the efficacy and safety of balloon pulmonary angioplasty (BPA) in patients
with non-operable chronic thromboembolic pulmonary hypertension (CTEPH) using the …

Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension―A Systematic Review and Meta-Analysis―

G Zoppellaro, MR Badawy, A Squizzato, G Denas… - Circulation …, 2019 - jstage.jst.go.jp
Background: Balloon pulmonary angioplasty (BPA) is a percutaneous treatment option for
patients affected by chronic thromboembolic pulmonary hypertension (CTEPH) and either …

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: results of a multicenter registry

A Ogawa, T Satoh, T Fukuda, K Sugimura… - … Quality and Outcomes, 2017 - Am Heart Assoc
Background—Balloon pulmonary angioplasty (BPA) is an alternative therapy for patients
with chronic thromboembolic pulmonary hypertension who are ineligible for pulmonary …

Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Insights from a Pilot Low-Volume Centre Study and a Comparative …

T Ivanauskiene, S Cesna, E Grigoniene, L Gumbiene… - Medicina, 2024 - mdpi.com
Background and Objectives: The aim of this study was to evaluate the effectiveness and
safety of balloon pulmonary angioplasty (BPA) in patients with inoperable chronic …

Balloon pulmonary angioplasty in the management of chronic thromboembolic pulmonary hypertension

S Higuchi, H Horinouchi, T Aoki, T Nishii, Y Ota… - …, 2022 - pubs.rsna.org
Chronic thromboembolic pulmonary hypertension (CTEPH), which is classified as group 4
pulmonary hypertension (PH) in the 2015 European Society of Cardiology/European …

Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

E Mahmud, M Patel, L Ang, D Poch - Pulmonary Circulation, 2021 - journals.sagepub.com
Balloon pulmonary angioplasty (BPA) is an emerging treatment option for patients with
chronic thromboembolic pulmonary hypertension (CTEPH) who have inoperable …